These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 22530301

  • 1. Enhancement of the in-vitro dissolution and in-vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of semisolid dispersion using Gelucire 44/14 as a carrier.
    Hussein A, El-Menshawe S, Afouna M.
    Pharmazie; 2012 Mar; 67(3):209-14. PubMed ID: 22530301
    [Abstract] [Full Text] [Related]

  • 2. Oil based nanocarrier for improved oral delivery of silymarin: In vitro and in vivo studies.
    Parveen R, Baboota S, Ali J, Ahuja A, Vasudev SS, Ahmad S.
    Int J Pharm; 2011 Jul 15; 413(1-2):245-53. PubMed ID: 21549187
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of an in vitro/in vivo correlation for lipid formulations of EMD 50733, a poorly soluble, lipophilic drug substance.
    Schamp K, Schreder SA, Dressman J.
    Eur J Pharm Biopharm; 2006 Apr 15; 62(3):227-34. PubMed ID: 16246538
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Etodolac-liquid-filled dispersion into hard gelatin capsules: an approach to improve dissolution and stability of etodolac formulation.
    Barakat NS.
    Drug Dev Ind Pharm; 2006 Aug 15; 32(7):865-76. PubMed ID: 16908424
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan.
    Chella N, Tadikonda R.
    Drug Dev Ind Pharm; 2015 Jun 15; 41(6):888-97. PubMed ID: 24796274
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S, Ortega M, Ma C.
    Int J Pharm; 2005 Sep 14; 301(1-2):209-16. PubMed ID: 16046087
    [Abstract] [Full Text] [Related]

  • 13. Formulation and pharmacokinetics of gelucire solid dispersions of flurbiprofen.
    Daravath B, Tadikonda RR, Vemula SK.
    Drug Dev Ind Pharm; 2015 Sep 14; 41(8):1254-62. PubMed ID: 25039470
    [Abstract] [Full Text] [Related]

  • 14. Reassessing bioavailability of silymarin.
    Javed S, Kohli K, Ali M.
    Altern Med Rev; 2011 Sep 14; 16(3):239-49. PubMed ID: 21951025
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir.
    Sinha S, Ali M, Baboota S, Ahuja A, Kumar A, Ali J.
    AAPS PharmSciTech; 2010 Jun 14; 11(2):518-27. PubMed ID: 20238187
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Nimodipine semi-solid capsules containing solid dispersion for improving dissolution.
    Sun Y, Rui Y, Wenliang Z, Tang X.
    Int J Pharm; 2008 Jul 09; 359(1-2):144-9. PubMed ID: 18499371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.